Download now
← Case studies
2023-08-15Continuous complianceRegulations

Streamlining Oracle Clinical One Software Releases

Discover how the team of experts at USDM simplified release management for a clinical research firm.

Discover how the team of experts at USDM simplified release management for a clinical research firm.

A global clinical research company faced the challenge of transitioning its clinical study data to Oracle Clinical One, a comprehensive clinical trial management system. However, the company encountered difficulties in efficiently managing the frequent quarterly releases – while maintaining compliance with the FDA's regulatory requirements.

With limited resources and a small in-house quality and validation team, the company needed help to cope with the substantial volume of data generated by the software. Furthermore, since the company had limited knowledge about Oracle Clinical One, they were unsure about any additional compliance gaps that might require attention.

The company sought validation expertise from USDM Life Sciences to address these challenges. USDM’s comprehensive solution aimed to streamline the entire process of handling the Oracle Clinical One software releases while ensuring compliance with regulatory standards. USDM leveraged its deep understanding of regulatory requirements and expertise in system validation to assist the company in achieving continuous compliance.

USDM delivered a fully validated system for both their Randomization and Trial Supply Management (RTSM) module and clinical studies. USDM also provided the company with a comprehensive validation plan serving as a roadmap to ensure future compliance and system reliability. USDM's Cloud Assurance managed services ensures that the company's system remains in a state of continuous compliance, efficiently managing the quarterly software releases from Oracle.

By engaging USDM Life Sciences, the clinical research company successfully addressed the challenges of managing frequent software releases. The comprehensive solution enabled the company to improve compliance, manage software updates efficiently, optimize internal resources, and enhance system reliability.

Start here

Put AI to work in life sciences — with the right guardrails underneath.

Start with a structured AI Readiness Assessment: fixed-fee, executive-ready, and built to surface the highest-value workflows first.

  • Workflow inventory and risk classification
  • Business value and readiness scoring
  • FDA CSA + EU AI Act + ISO 42001 gap analysis
  • Prioritized 90-day roadmap by impact, risk, and effort

Start here

Talk to USDM

Tell us what workflow or outcome you want to improve and we'll map the right AI, governance, and delivery path.

By submitting this form, you agree to USDM’s Privacy Policy and consent to receive communications from USDM. You can unsubscribe at any time using the link in our emails.